Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	1 Setraline	133
Overall Study	STARTED	2 CBT	139
Overall Study	STARTED	3 Combination Setraline and CBT	140
Overall Study	STARTED	4 Placebo	76
Overall Study	COMPLETED	1 Setraline	110
Overall Study	COMPLETED	2 CBT	133
Overall Study	COMPLETED	3 Combination Setraline and CBT	127
Overall Study	COMPLETED	4 Placebo	61
Overall Study	NOT COMPLETED	1 Setraline	23
Overall Study	NOT COMPLETED	2 CBT	6
Overall Study	NOT COMPLETED	3 Combination Setraline and CBT	13
Overall Study	NOT COMPLETED	4 Placebo	15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00052078/flow